We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+2.87%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$5.45B
AUM Growth
+$2.36B
(+76%)
Cap. Flow
+$2.34B
Cap. Flow
% of AUM
42.99%
Top 10 Holdings %
Top 10 Hldgs %
5.62%
Holding
2,708
New
491
Increased
1,179
Reduced
746
Closed
280
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paychex
PAYX
|
+$37.5M |
| 2 |
Altria Group
MO
|
+$31.8M |
| 3 |
Ciena
CIEN
|
+$28.6M |
| 4 |
LyondellBasell Industries
LYB
|
+$27.8M |
| 5 |
Veeva Systems
VEEV
|
+$26.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$25.3M |
| 2 |
CMS Energy
CMS
|
+$16.5M |
| 3 |
Humana
HUM
|
+$15.1M |
| 4 |
Northrop Grumman
NOC
|
+$13.9M |
| 5 |
Sysco
SYY
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.52% |
| 2 | Healthcare | 13.04% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 12.62% |
| 5 | Industrials | 12.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Verastem
VSTM
$518M
| $25K | ﹤0.01% |
1,382
+3
| +0.2% | +$68 |
|
2377
Aclaris Therapeutics
ACRS
$908M
| $24K | ﹤0.01% |
11,033
-10,115
| -48% | -$55.1K |
|
|
ALBO
2378
DELISTED
Albireo Pharma Inc
ALBO
| $24K | ﹤0.01% |
+759
| New | +$25.4K |
|
2379
Babcock & Wilcox
BW
$1.46B
| $23K | ﹤0.01% |
6,741
-498
| -7% | -$1.92K |
|
2380
Civeo
CVEO
$357M
| $23K | ﹤0.01% |
1,099
-366
| -25% | -$7.91K |
|
|
GNC
2381
DELISTED
GNC Holdings, Inc.
GNC
| $23K | ﹤0.01% |
15,655
+10,861
| +227% | +$20.6K |
|
|
OSG
2382
DELISTED
Overseas Shipholding Group Inc.
OSG
| $21K | ﹤0.01% |
11,074
-38,021
| -77% | -$70.4K |
|
|
PEI
2383
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $21K | ﹤0.01% |
+220
| New | +$21.4K |
|
2384
Zillow
Z
$8.28B
| $19K | ﹤0.01% |
420
-59,416
| -99% | -$2.37M |
|
|
PVLA
2385
Palvella Therapeutics
PVLA
$2.19B
| $18K | ﹤0.01% |
48
+29
| +153% | +$8.65K |
|
|
SRG
2386
Seritage Growth Properties
SRG
$139M
| $17K | ﹤0.01% |
400
| – | – |
|
2387
Chewy
CHWY
$9.79B
| $16K | ﹤0.01% |
+451
| New | +$15.2K |
|
2388
Buckle
BKE
$2.35B
| $15K | ﹤0.01% |
857
-13,071
| -94% | -$230K |
|
2389
Trex
TREX
$5.08B
| $15K | ﹤0.01% |
426
-53,920
| -99% | -$1.83M |
|
|
VTLE
2390
DELISTED
Vital Energy
VTLE
| $15K | ﹤0.01% |
266
-5,490
| -95% | -$332K |
|
2391
W&T Offshore
WTI
$488M
| $15K | ﹤0.01% |
3,066
-203,317
| -99% | -$1.1M |
|
|
ASAP
2392
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $15K | ﹤0.01% |
+116
| New | +$19.8K |
|
2393
Fortis
FTS
$28.7B
| $14K | ﹤0.01% |
345
-25,800
| -99% | -$976K |
|
2394
Nordson
NDSN
$17.3B
| $14K | ﹤0.01% |
100
-4,216
| -98% | -$580K |
|
2395
Northern Oil and Gas
NOG
$2.17B
| $14K | ﹤0.01% |
701
-1,459
| -68% | -$33.7K |
|
2396
UroGen Pharma
URGN
$2.29B
| $14K | ﹤0.01% |
400
-10,838
| -96% | -$400K |
|
|
RPT
2397
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $13K | ﹤0.01% |
1,106
-41,693
| -97% | -$514K |
|
|
AJRD
2398
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $13K | ﹤0.01% |
300
-9,788
| -97% | -$365K |
|
|
OBE
2399
Obsidian Energy
OBE
$615M
| $12K | ﹤0.01% |
10,001
-4,779
| -32% | -$8.62K |
|
|
YMAB
2400
DELISTED
Y-mAbs Therapeutics
YMAB
| $12K | ﹤0.01% |
+520
| New | +$11.9K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2019 Portfolio in Review
As of Q2 2019, Cubist Systematic Strategies held 2,708 positions worth $5.45B, up 76% from $3.09B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
Cubist Systematic Strategies deployed $2.34B of net new capital in Q2 2019, opening 491 new positions and adding to 1,179 existing holdings. Its largest new stake was Alexandria Real Estate Equities: 126,551 shares worth $17.9M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $25.3M trimmed.
- Cubist Systematic Strategies's largest Q2 2019 buy was Alexandria Real Estate Equities: 126,551 shares worth $17.9M.
- Cubist Systematic Strategies added most to Paychex in Q2 2019, an estimated $37.5M increase.
- Cubist Systematic Strategies's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $25.3M.
- Cubist Systematic Strategies fully exited Henry Schein in Q2 2019, selling an estimated $7.04M.
- Cubist Systematic Strategies's ten largest holdings make up 5.6% of its $5.45B portfolio in Q2 2019.
- Cubist Systematic Strategies opened 491 new positions and closed 280 in Q2 2019.
- Cubist Systematic Strategies's portfolio value rose 76% quarter-over-quarter to $5.45B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2019, filed 14 Aug 2019.